On the local cardiac renin angiotensin system. Basic and clinical implications

Walmor C De Mello1, Edward D Frohlich

  • 1School of Medicine, UPR, San Juan, PR 00936-5067, USA. walmor.de-mello@upr.edu

Peptides
|July 7, 2011
PubMed

Insights

This review highlights the heart's local renin-angiotensin system, crucial in heart failure and hypertension. Novel findings reveal cell swelling triggers arrhythmias and AT1 receptors act as mechanosensors, impacting heart function.

Area of Science:

  • Cardiovascular Physiology
  • Renal Physiology
  • Molecular Cardiology

Background:

  • The heart possesses a local renin-angiotensin system (RAS).
  • An intracrine component of the cardiac RAS is activated during pathological conditions such as heart failure and hypertension.
  • Existing research suggests implications for cardiovascular disease management.

Purpose of the Study:

  • To reevaluate experimental and clinical evidence for a local cardiac RAS.
  • To discuss the role of the intracrine cardiac RAS in heart failure and hypertension.
  • To explore novel findings regarding cell swelling, cardiac arrhythmias, and AT1 receptor function.

Main Methods:

  • Review of existing experimental and clinical evidence.
  • Analysis of the functional intracrine component of the cardiac RAS.
  • Evaluation of the role of salt loading in activating the cardiac RAS.

Main Results:

  • Cell swelling impairs cell coupling and impulse propagation via ionic channels, leading to cardiac arrhythmias.
  • Angiotensin II (Ang II) type 1 (AT1) receptors function as mechanosensors, altering heart function independently of Ang II.
  • Salt loading activates the local cardiac renin-angiotensin system, with significant consequences for heart function.

Conclusions:

  • The local cardiac renin-angiotensin system, including its intracrine component, plays a critical role in cardiovascular pathology.
  • Novel mechanisms involving cell swelling and AT1 receptor mechanosensing contribute to cardiac dysfunction and arrhythmias.
  • Understanding these pathways offers potential therapeutic targets for heart failure and hypertension.

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Antihypertensive Drugs: Action of β1 Blockers01:17

Antihypertensive Drugs: Action of β1 Blockers

β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this, β1-blockers...
Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...